Latest Growth Initiatives News

Compumedics maintains robust sales momentum but faces FY26 revenue timing challenges due to MEG installation delays and a cautious Somfit D rollout. The company expects solid year-on-year growth and positions for improved execution in FY27.

Lynas Rare Earths reported a record A$265 million quarterly revenue in Q3 FY26, driven by higher NdPr prices and production milestones including early Samarium oxide output. The company secured a 10-year Malaysian operating licence and extended a key supply deal with Japanese partner JARE through 2038.

Butn Limited surged to record monthly originations and revenue in March 2026, while cutting costs and completing a share buy-back, underscoring its drive to scale embedded SME funding solutions.

Nutritional Growth Solutions (ASX: NGS) has completed a major operational reset, achieving normalised profitability, eliminating all debt, and replenishing inventory to support renewed growth.

Stanmore Resources defied a four-year low in metallurgical coal prices to deliver record saleable production and robust cash flow in 2025, while maintaining a strong safety record and advancing key development projects.

Lumos Diagnostics has secured a key FDA 510(k) clearance with CLIA waiver for its FebriDx rapid test, unlocking a US$1 billion-plus market opportunity and triggering milestone payments exceeding US$6 million. The company reported a 37% revenue jump in Q3 FY26, supported by a A$20 million placement and ongoing clinical and development projects.

29Metals Limited (ASX:29M) swung to a $24 million net profit in 2025, powered by steady copper output at Golden Grove despite seismic disruptions, cost efficiencies, and key progress on growth projects including Gossan Valley and Capricorn Copper restart.

NEXTDC has boosted its pro forma contracted utilisation by 60% to 667MW, prompting a A$1.5 billion entitlement offer and an expanded capital plan to accelerate its Western Sydney data centre developments.

29Metals confirms additional groundworks at Xantho Extended will push back full mining resumption, leading to lowered zinc, gold, and silver production forecasts while maintaining copper output.

Ovanti Limited has raised $5.27 million through a discounted placement, aiming to accelerate its global Buy Now Pay Later platform and Super App development with AI integration and merchant expansion.

AVITA Medical’s Cohealyx-I study interim results show a significant acceleration in skin grafting time for full-thickness wounds, reducing mean time to graft from 33.2 to 13.6 days. The ongoing trial’s promising data could reshape wound care protocols.

Love Group Global Ltd reported a 15% decline in quarterly customer cash receipts to $884k in Q3 FY26, driven by a sharp drop in Hong Kong. Despite this, the company maintained positive net operating cash flow and is pursuing growth in US and UK markets.